Literature DB >> 34301307

Assessment of TSLP, IL 25 and IL 33 in patients with shrimp allergy.

Natalia Ukleja-Sokołowska1, Magdalena Żbikowska-Gotz2, Kinga Lis2, Rafał Adamczak3, Zbigniew Bartuzi2.   

Abstract

BACKGROUND: Shrimp allergy is a growing problem among the European population. TSLP, IL-25 and IL-33 are involved in the pathophysiology of allergic diseases, including asthma and atopic dermatitis, as they activate the Th2-dependent immune response.
METHODS: Thirty-seven patients (18 male and 19 female) with a positive history of symptoms associated with shrimp consumption were selected. All patients had blood samples taken to assess the concentration of allergen-specific IgE (sIgE) to house dust mites (HDM) and shrimp (Singleplex, quantitative method with cut off value > 0,35 kAU/L) as well as the level of allergen components using the ImmunoCap ISAC method (Microarray test, semi-quantitative with cut off value > 0,3 ISU-E). The concentrations of TSLP, IL-25 and IL-33 in the patients' blood serum was assessed using the ELISA method (Cusabio). Twenty patients with negative allergy history of allergic disease tests were included in the control group.
RESULTS: Among the 37 shrimp-allergic patients, ImmunoCap ISAC was identified the presence of sIgE to the available shrimp allergen components in only 14 cases (37.8%). TSLP and IL25 levels were significantly higher in the study group. No statistically significant correlation was found between the concentration of analyzed alarmins and the concentration of sIgE level to shrimp or HDM between the study and control groups. No statistically significant correlation was found between poly-sensitization occurring in patients and levels of TSLP, IL-25 and IL-33 .
CONCLUSION: In shrimp-allergic patients, the concentrations of TSLP and IL-25 were significantly higher than in the control group (1.33 vs. 0.49 and 157 vs. 39.36, respectively). There was no correlation between the concentrations of TSLP, IL-25 and IL-33 and the concentration of sIgE in the patients or the number of allergen components that the patients were sensitized to. TRIAL REGISTRATION: Bioethics Committee 147/2015, 11.03.2015.
© 2021. The Author(s).

Entities:  

Keywords:  Der p 1; Der p 2; House dust mite; IL-25; IL-33; ImmunoCap ISAC; Pen m 1; Shrimp allergy; TSLP; sIgE

Year:  2021        PMID: 34301307     DOI: 10.1186/s13223-021-00576-9

Source DB:  PubMed          Journal:  Allergy Asthma Clin Immunol        ISSN: 1710-1484            Impact factor:   3.406


  18 in total

1.  TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis.

Authors:  U Nygaard; M Hvid; C Johansen; M Buchner; R Fölster-Holst; M Deleuran; C Vestergaard
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-05-06       Impact factor: 6.166

2.  Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis.

Authors:  Y Sano; K Masuda; R Tamagawa-Mineoka; H Matsunaka; Y Murakami; R Yamashita; E Morita; N Katoh
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

3.  Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.

Authors:  Yasutomo Imai; Koubun Yasuda; Yoshiko Sakaguchi; Takashi Haneda; Hitoshi Mizutani; Tomohiro Yoshimoto; Kenji Nakanishi; Kiyofumi Yamanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

4.  Shrimp allergy beyond Tropomyosin in Italy: clinical relevance of Arginine Kinase, Sarcoplasmic calcium binding protein and Hemocyanin.

Authors:  M G Giuffrida; D Villalta; G Mistrello; S Amato; R Asero
Journal:  Eur Ann Allergy Clin Immunol       Date:  2014-09

5.  Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases.

Authors:  Naina Gour; Stephane Lajoie; Ursula Smole; Marquitta White; Donglei Hu; Pagé Goddard; Scott Huntsman; Celeste Eng; Angel Mak; Sam Oh; Jung-Hyun Kim; Annu Sharma; Sophie Plante; Ikhlass Haj Salem; Yvonne Resch; Xiao Xiao; Nu Yao; Anju Singh; Susanne Vrtala; Jamila Chakir; Esteban G Burchard; Andrew P Lane; Marsha Wills-Karp
Journal:  Sci Immunol       Date:  2018-02-23

6.  IL-25 and IL-25 receptor expression on eosinophils from subjects with allergic asthma.

Authors:  Wei Tang; Steven G Smith; Sue Beaudin; Benny Dua; Karen Howie; Gail Gauvreau; Paul M O'Byrne
Journal:  Int Arch Allergy Immunol       Date:  2013-11-16       Impact factor: 2.749

7.  Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma.

Authors:  H Han; W Xu; M B Headley; H K Jessup; K S Lee; M Omori; M R Comeau; A Marshak-Rothstein; S F Ziegler
Journal:  Mucosal Immunol       Date:  2012-02-22       Impact factor: 7.313

8.  The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil-basophil lineage commitment: Relevance to atopic sensitization.

Authors:  Claudia C K Hui; Sina Rusta-Sallehy; Ilan Asher; Delia Heroux; Judah A Denburg
Journal:  Immun Inflamm Dis       Date:  2014-05-09

9.  IL-33 promotes gastrointestinal allergy in a TSLP-independent manner.

Authors:  H Han; F Roan; L K Johnston; D E Smith; P J Bryce; S F Ziegler
Journal:  Mucosal Immunol       Date:  2017-06-28       Impact factor: 7.313

10.  Prevalence of Food Sensitization and Food Allergy in Children Across Europe.

Authors:  Sarah A Lyons; Michael Clausen; André C Knulst; Barbara K Ballmer-Weber; Montserrat Fernandez-Rivas; Laura Barreales; Christian Bieli; Ruta Dubakiene; Cristina Fernandez-Perez; Monika Jedrzejczak-Czechowicz; Marek L Kowalski; Tanya Kralimarkova; Ischa Kummeling; Tihomir B Mustakov; Nikolaos G Papadopoulos; Todor A Popov; Paraskevi Xepapadaki; Paco M J Welsing; James Potts; E N Clare Mills; Ronald van Ree; Peter G J Burney; Thuy-My Le
Journal:  J Allergy Clin Immunol Pract       Date:  2020-04-21
View more
  1 in total

Review 1.  The Role of Airway Epithelial Cell Alarmins in Asthma.

Authors:  Christiane E Whetstone; Maral Ranjbar; Hafsa Omer; Ruth P Cusack; Gail M Gauvreau
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.